Finance

Lists
Q1 2027 earnings • released • EPS beat +17.22% • Revenue miss -5.60%
See results
ANTHEM:NSE
Anthem BioSciences Ltd
₹785.15
+0.80%
(+6.25) 1D
Jul 23, 10:52:09 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ANTHEM...
Open
₹767.10
High
₹789.90
Low
₹767.10
Mkt. cap
442.59B
Avg. vol.
775.16K
Volume
166.70K
Dividend
0.25%
Quarterly dividend
₹0.50
Ex-dividend date
Jun 25, 2026
P/E ratio
75.27
52-wk high
₹873.50
52-wk low
₹579.15
EPS
₹10.43
No. of employees
2K
Open
₹767.10
High
₹789.90
Low
₹767.10
Mkt. cap
442.59B
Avg. vol.
775.16K
Volume
166.70K
Dividend
0.25%
Quarterly dividend
₹0.50
Ex-dividend date
Jun 25, 2026
P/E ratio
75.27
52-wk high
₹873.50
52-wk low
₹579.15
EPS
₹10.43
No. of employees
2K
News stories
From sources across the web
About Anthem BioSciences Ltd
CEO-
Employees2.28K
Founded2006
Headquarters-
SectorHealth care
Websiteanthembio.com
Last report
Jul 22, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹2.11 / ₹1.80
+17.22%beat
Revenue / Est. (INR)
4.18B / 4.43B
-5.60%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.50B
4.23B
6.16B
4.18B
Cost of goods sold
2.23B
1.43B
2.57B
-
Cost of revenue
2.23B
1.43B
2.57B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
677.16M
704.79M
745.64M
-
Operating expense
1.42B
1.58B
1.22B
-
Total operating expenses
3.66B
3.00B
3.80B
-
Operating income
1.84B
1.23B
2.36B
-
Other non operating income
482.29M
335.30M
-1.05B
-
EBT including unusual items
2.30B
1.30B
2.78B
-
EBT excluding unusual items
2.30B
1.56B
2.67B
-
Income tax expense
561.74M
376.57M
881.59M
-
Effective tax rate
24.47%
28.86%
31.72%
-
Other operating expenses
410.47M
528.85M
79.01M
-
Net income
1.73B
928.17M
1.90B
-
Net profit margin
31.53%
21.93%
30.81%
-
Earnings per share
-
1.96
-
2.11
Interest and investment income
-
-
792.70M
-
Interest expense
-30.31M
-3.52M
-15.47M
-
Net interest expenses
-30.31M
-3.52M
777.23M
-
Depreciation and amortization charges
334.99M
345.33M
395.91M
-
EBITDA
2.14B
1.45B
2.69B
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer